Wheaton Industries Expands Product Line with Acquisition of CELLine
July 9, 2012
PITTSBURGH,- Incline Equity Partners and portfolio company Wheaton Industries Inc. (“Wheaton”) announced today the acquisition of CELLine, a division of Wilson Wolf Manufacturing Corporation that manufactures disposable cell culture flasks. This is the second add-on acquisition for Wheaton Industries since Incline’s initial investment in June 2010. In February 2011, Wheaton acquired Laboratory Sales Limited (LSL) [...]
Luminex Corporation Announces Agreement to Acquire GenturaDx
July 9, 2012
AUSTIN, Texas, -- Luminex Corporation (NASDAQ: LMNX) today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true [...]
FEI Buys the Assets of Its Korean Agent
July 9, 2012
HILLSBORO, Ore., -- FEI Company (Nasdaq:FEIC), a leading instrumentation company providing imaging and analysis systems for research and industry, today announced that it has purchased certain assets of AP Tech of Suwon, South Korea for $12 million. AP Tech has over 40 employees primarily engaged in sales and service and has been FEI's agent in [...]
New Perfinity Integrated Digestion Platform Simplifies Protein Sample Preparation
July 9, 2012
COLUMBIA, Md., — In partnership with Perfinity Biosciences, Shimadzu Scientific Instruments has released the Perfinity Integrated Digestion Platform (IDP). Based on the Perfinity Workstation, the Perfinity IDP system automates key proteomics workflow steps to significantly reduce sample preparation times and enhance reproducibility. Traditionally, manual sample preparation techniques involving 18-hour tryptic digestion to reverse-phase HPLC and [...]
WHEATON Announces Acquisition of CELLineTM
July 9, 2012
WHEATON has acquired the CELLine dual membrane, cell culture flasks from Wilson Wolf Manufacturing Corporation. WHEATON has also entered into a long term strategic partnership with Wilson Wolf Manufacturing Corporation for further product development in high density cell culture devices for the production of concentrated, cell secreted products. CELLine Flasks are known by their loyal [...]
July 9, 2012
Järfälla, Sweden, – Silex Microsystems, the world’s largest pure-play MEMS foundry, today announced that VINNOVA, the Swedish Governmental Agency for Innovation Systems, has awarded a nearly 10M SEK grant towards a 30M SEK program to a consortium of 10 Swedish companies to advance high-tech manufacturing of MEMS-based gas sensing systems in Sweden – the global [...]
New, Fully Automated BD MAX™ MRSA Assay Rapidly Identifies Patients Colonized with Deadly Superbug
July 9, 2012
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it received FDA clearance to market the BD MAX™ MRSA molecular test in the United States. The assay is performed on the fully-automated BD MAX™ System and is designed to rapidly and accurately identify patients colonized with methicillin-resistant [...]
Chiral Technologies Welcomes Dr. Jauh-Tzuoh Lee as Technology Manager
July 9, 2012
WEST CHESTER, Pa. — Chiral Technologies, Inc., (CTI) announced that Jauh-Tzuoh (J.T.) Lee, Ph.D., has joined the company as Technology Manager. In this position, Dr. Lee will be responsible for planning and directing CTI’s technology activities and providing leadership in the development of new products. Reporting to Joseph Barendt, Ph.D., Chief Operating Officer, Dr. Lee [...]
July 9, 2012
LEXINGTON, Mass -- BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the in vitro and in vivo kinase expression in the MAP kinase pathway at the 22nd Biennial European Association for Cancer Research (EACR) Congress, held in Barcelona, Spain, July [...]
Horizon Discovery and Bayer Collaborate to Develop Cell Line Models to Support Oncology Programs
July 9, 2012
Cambridge, UK,- Horizon Discovery Ltd (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced it has signed a collaboration agreement with Bayer Pharma AG (Bayer) to develop preclinical cell line models that will support Bayer’s oncology research and development programs, using Horizon’s precision genome editing technology, GENESIS™. The [...]
